Trial intelligence / Profile preview

Effect of Food on Pharmacokinetics of Fadanafil in Healthy Subjects

NCT04467203Phase 1Completed

Sponsor
Sihuan Pharmaceutical
Start
Apr 2019
Primary completion
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of Fadanafil in erectile dysfunction (ED) (2 arms), sponsored by Sihuan Pharmaceutical. Primary endpoint: Pharmacokinetic Parameter AUC(0-24) at 36 hours. Started Apr 2019; status: completed.

02

Drugs

Fadanafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT04467203.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04467203.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call